Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.47 |
| ▸ | MAOB | P27338 | 5/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL21596647 | 0.90 | MAOA (0.54) | MAOAMAOBCA12CA9AKR1B1 | |
| Xanthene SCHEMBL28265232 | 0.88 | MAOA (0.63) | MAOAMAOBACSL1FDPSBLM | |
| SCHEMBL29364777 | 0.84 | MAOA (0.65) | MAOAMAOBCA12CA9AKR1B1 | |
| SCHEMBL27806543 | 0.84 | MAOA (0.65) | MAOAMAOBCA12CA9AKR1B1 | |
| SCHEMBL30487859 | 0.84 | MAOA (0.65) | MAOAMAOBCA12CA9AKR1B1 | |
| SCHEMBL44758 | 0.84 | MAOA (0.65) | MAOAMAOBCA12CA9AKR1B1 | |
| Hydrochloric Acid SCHEMBL29040933 | 0.82 | MAOA (0.62) | MAOAMAOBCA12CA9AKR1B1 | |
| SCHEMBL29011578 | 0.82 | MAOA (0.62) | MAOAMAOBCA12CA9AKR1B1 | |
| Charcoal, Activated SCHEMBL31096962 | 0.82 | MAOA (0.62) | MAOAMAOBCA12CA9AKR1B1 | |
| SCHEMBL28124501 | 0.82 | MAOA (0.62) | MAOAMAOBCA12CA9AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3810621-B1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2024-08-07 | — | — | EP | disclosed |
| US-11767338-B2 | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers | BASF SE (DE) | 2023-09-26 | — | — | US | disclosed |
| US-20210253617-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SCHWEIZ AG (CH) | 2021-08-19 | — | — | US | disclosed |
| EP-3810621-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2021-04-28 | — | — | EP | disclosed |
| CN-112292382-A | 3-phenylbenzofuran-2-one diphosphate derivatives as stabilizers | 巴斯夫欧洲公司 | 2021-01-29 | — | — | CN | disclosed |
| WO-2019243267-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | BASF SE (DE) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253617-A1 | 3-PHENYL-BENZOFURAN-2-ONE DIPHOSPHATE DERIVATIVES AS STABILIZERS | DHPS, PIR, NQO1 | MAOA 264/4885MAOB 313/4885CA12 4747/4885 |
| US-11767338-B2 | 3-phenyl-benzofuran-2-one diphosphate derivatives as stabilizers | DHPS, PIR, NQO1 | MAOA 264/4885MAOB 313/4885CA12 4747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.